Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Aronson

Showing results (181-190 of 634) with videos related to

Pageof 64
Sort By:
British Journal of Clinical Pharmacology|March 24, 2007
Compliance, concordance, adherenceJeffrey K Aronson
BMJ (Clinical Research Ed.)|January 26, 2012
System rather than target driven approach needed to discover beneficial drug effectsJeffrey K Aronson
British Journal of Clinical Pharmacology|February 25, 2012
Finding a VOICE for UK clinical pharmacologyJeffrey K Aronson
QJM : Monthly Journal of the Association of Physicians|February 20, 1999
Digoxin revisitedJ K Aronson
The Journal of Ambulatory Care Management|December 29, 2007
Something new every day: defining innovation and innovativeness in drug therapyJeffrey K Aronson
BMJ (Clinical Research Ed.)|June 13, 2025
When I use a word . . . Managing pharmaceutical stocks stocklesslyJeffrey K Aronson
BMJ (Clinical Research Ed.)|June 28, 2024
When I use a word . . . The languages of medicines-defining a street drug operationallyJeffrey K Aronson
British Journal of Clinical Pharmacology|September 18, 2004
Classifying drug interactionsJ K Aronson
European Journal of Clinical Pharmacology|January 1, 1992
PenicillinJ K Aronson
British Journal of Clinical Pharmacology|August 26, 2004
Over-the-counter medicinesJ K Aronson
Pageof 64

Showing results (181-190 of 634) with videos related to

Sort By:
Pageof 64
British Journal of Clinical Pharmacology|March 24, 2007
Compliance, concordance, adherenceJeffrey K Aronson
BMJ (Clinical Research Ed.)|January 26, 2012
System rather than target driven approach needed to discover beneficial drug effectsJeffrey K Aronson
British Journal of Clinical Pharmacology|February 25, 2012
Finding a VOICE for UK clinical pharmacologyJeffrey K Aronson
QJM : Monthly Journal of the Association of Physicians|February 20, 1999
Digoxin revisitedJ K Aronson
The Journal of Ambulatory Care Management|December 29, 2007
Something new every day: defining innovation and innovativeness in drug therapyJeffrey K Aronson
BMJ (Clinical Research Ed.)|June 13, 2025
When I use a word . . . Managing pharmaceutical stocks stocklesslyJeffrey K Aronson
BMJ (Clinical Research Ed.)|June 28, 2024
When I use a word . . . The languages of medicines-defining a street drug operationallyJeffrey K Aronson
British Journal of Clinical Pharmacology|September 18, 2004
Classifying drug interactionsJ K Aronson
European Journal of Clinical Pharmacology|January 1, 1992
PenicillinJ K Aronson
British Journal of Clinical Pharmacology|August 26, 2004
Over-the-counter medicinesJ K Aronson
Pageof 64